Made-to-measure treatment battling colon cancer by computer
Colon cancer treatment could be revolutionised with a pioneering computer system to help doctors fight the disease.
Colon cancer is the third biggest killer cancer and the £2 million EU-funded project could mean faster and more accurate diagnosis, leading to better treatment outcomes for patients.
The system identifies gene mutations that contribute to the growth of cancerous tumours, giving doctors vital details about the type of cancer and its possible causes. It works by matching information from a simple blood test to gene databases of other cases, equipping doctors with a valuable tool to make decisions on long-term care.
It helps them determine the most effective way to battle the condition and, by speeding up the time to make treatment decisions, it will boost survival rates and reduce costs incurred by inaccurate diagnosis. It also means patients will no longer need to undergo invasive procedures unnecessarily.
The project has been masterminded by a team across the EU, comprising leading computer experts working alongside cancer specialists, biomedical scientists and genetic engineers.
It heralds the first major step towards tailor-made, personalised medical treatment.
Dr Babak Akhgar leads the seven-strong team working on the project, in the Universitys Cultural, Communication and Computing Research Institute. He said: "Its very exciting. It is potentially a defining IT project for the future of cancer care and is a huge step towards cutting cancer rates across the board because once the system is established it can be adapted to be applied to other cancers. Theres a real chance of helping save lives. It harnesses the know-how in this field across Europe, bringing it to the desktop of any healthcare professional. It means treatment is backed up by hard facts, rather than reliant on a specialists interpretation and experience alone.
"It will be the first breakthrough in personalised medicine. Its like being able to take a tablet not just for symptom relief, but to treat the exact illness you have. This paves the way for 25th century drugs that are tailor-made to treat an individuals problems, rather than mass-produced drugs for all."
Sheffield Hallam University is one of eight research partners from across Europe working on the project, called MATCH. The state-of-the-art technology could be in use in hospitals within five years.
The next phase of MATCH is collecting data from colon cancer patient databases in Italy and Poland, which will be fed into the system and tested.
Pharmaceutical firms will also be brought into the project to feed into talks on potential new drug design and discoveries.
Kelly Hill | alfa
The most recent press releases about innovation >>>
Die letzten 5 Focus-News des innovations-reports im Überblick:
Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.
As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...
Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.
Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...
For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.
While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...
An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.
The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...
A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.
Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...